The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
暂无分享,去创建一个
D. Vlahov | R. Garfein | D. Holtzman | D. D. Des Jarlais | E. Golub | V. Barry | L. Ouellet | S. Hudson
[1] R. Garfein,et al. Distributive syringe sharing among young adult injection drug users in five U.S. cities. , 2007, Drug and alcohol dependence.
[2] R. Garfein,et al. Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. , 2007, Drug and alcohol dependence.
[3] R. Garfein,et al. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). , 2007, Drug and alcohol dependence.
[4] S. Strathdee,et al. HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan , 2007, Emerging infectious diseases.
[5] V. Rustgi. The epidemiology of hepatitis C infection in the United States , 2007, Journal of Gastroenterology.
[6] D. Huo,et al. Needle Exchange and Injection-Related Risk Behaviors in Chicago: A Longitudinal Study , 2007, Journal of acquired immune deficiency syndromes.
[7] R. Garfein,et al. Trends in Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Prevalence, Risk Behaviors, and Preventive Measures among Seattle Injection Drug Users Aged 18–30 Years, 1994–2004 , 2007, Journal of Urban Health.
[8] C. Day,et al. Self reported risk behaviour among injecting drug users: Self versus assisted questionnaire completion , 2007, AIDS care.
[9] N. Wright,et al. A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users , 2006, Harm Reduction Journal.
[10] M. Alter,et al. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.
[11] H. Hagan,et al. Changes in injection risk behavior associated with participation in the seattle needle-exchange program , 2000, Journal of Urban Health.
[12] R. Garfein,et al. Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. , 2005, Drug and alcohol dependence.
[13] D. Huo,et al. HIV Risk Practices Among Needle Exchange Users and Nonusers in Chicago , 2004, Journal of acquired immune deficiency syndromes.
[14] Don C Des Jarlais,et al. Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. , 2004, Addiction.
[15] R. Garfein,et al. The Use of Needle Exchange by Young Injection Drug Users , 2003, Journal of acquired immune deficiency syndromes.
[16] M. Busch,et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.
[17] D. Vlahov,et al. Does Bleach Disinfection of Syringes Protect Against Hepatitis C Infection Among Young Adult Injection Drug Users? , 2002, Epidemiology.
[18] D. Vlahov,et al. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. , 2002, AIDS education and prevention : official publication of the International Society for AIDS Education.
[19] R. Garfein,et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. , 2002, American journal of epidemiology.
[20] R. Brookmeyer,et al. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. , 2002, American journal of epidemiology.
[21] A. Estrada. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. , 2002, Public health reports.
[22] D. Vlahov,et al. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. , 2001, Journal of substance abuse.
[23] D. Gibson,et al. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. , 2001, AIDS.
[24] A. Moss,et al. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco , 2001, Hepatology.
[25] D. Vlahov,et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. , 2001, American journal of public health.
[26] J. Duchin,et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. , 2001, American journal of public health.
[27] D. Vlahov,et al. Prevention of HIV Infection in Street‐Recruited Injection Drug Users , 2000, Journal of acquired immune deficiency syndromes.
[28] H. Hagan,et al. Methadone treatment and hiv and hepatitis band C risk reduction among injectiors in the seattle area , 2000, Journal of urban health : bulletin of the New York Academy of Medicine.
[29] B. Edlin,et al. The effect of syringe exchange use on high-risk injection drug users: a cohort study , 2000, AIDS.
[30] Inda,et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.
[31] N. Weiss,et al. Reply to “Invited Commentary: Needle Exchange—No Help for Hepatitis?” by Moss and Hahn , 1999 .
[32] N. Weiss,et al. Syringe exchange and risk of infection with hepatitis B and C viruses. , 1999, American journal of epidemiology.
[33] A. Moss,et al. Invited commentary: needle exchange--no help for hepatitis? , 1999, American journal of epidemiology.
[34] D. Vlahov,et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[35] R Brookmeyer,et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[36] N. Crofts,et al. Methadone maintenance and hepatitis C virus infection among injecting drug users. , 1997, Addiction.
[37] J. Kaldor,et al. Effectiveness of needle-exchange programmes for prevention of HIV infection , 1997, The Lancet.
[38] K. Vranizan,et al. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[39] A. Plant,et al. Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus , 1977, Australian and New Zealand journal of public health.
[40] G. Rezza,et al. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. , 1996, Scandinavian journal of infectious diseases.
[41] M. Alter,et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. , 1995, American journal of public health.
[42] D. Vlahov,et al. Correlates of Hepatitis C Virus Infections among Injection Drug Users , 1995, Medicine.
[43] J. Watters,et al. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. , 1994, JAMA.
[44] A. Lazzarin,et al. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study. , 1992, American journal of epidemiology.
[45] J. Goudsmit,et al. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. , 1990, The Journal of infectious diseases.
[46] J. Parry,et al. Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year. , 1989, AIDS.